Financhill
Back

Cara Therapeutics Stock Price Chart

Free Stock Analysis Report: Get a clear concise Stock Rating

Analyze Any Stock Free
Sell
27

CARA
Cara Therapeutics

Last Price:
$4.82
Seasonality Move:
10.97%

7 Day Trial

ALL ACCESS PASS

$ 7

Unlock the power of "two-minute trades"

Learn how today!
  • The current trend is moderately bullish and CARA is experiencing buying pressure, which is a positive indicator for future bullish movement.

Cara Therapeutics Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 5.16 Sell
20-day SMA: 4.55 Buy
50-day SMA: 3.99 Buy
200-day SMA: 5.22 Sell
8-day EMA: 4.98 Sell
20-day EMA: 4.67 Buy
50-day EMA: 4.19 Buy
200-day EMA: 7.22 Sell

Cara Therapeutics Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.38 Buy
Relative Strength Index (14 RSI): 53.38 Buy
Chaikin Money Flow: 79077 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (3.25 - 5.35) Buy
Bollinger Bands (100): (3.07 - 4.45) Buy

Cara Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Cara Therapeutics Stock

Is Cara Therapeutics Stock a Buy?

  • Cara Therapeutics share price is 4.75 while CARA 8-day simple moving average is 5.16, which is a Sell signal.
  • The stock price of CARA is 4.75 while Cara Therapeutics 20-day SMA is 4.55, which makes it a Buy.
  • Cara Therapeutics 50-day simple moving average is 3.99 while CARA share price is 4.75, making it a Buy technically.
  • CARA stock price is 4.75 and Cara Therapeutics 200-day simple moving average is 5.22, creating a Sell signal.

CARA Technical Analysis vs Fundamental Analysis

Sell
27
Cara Therapeutics (CARA) is a Sell

Is Cara Therapeutics a Buy or a Sell?

  • Cara Therapeutics stock is rated a Sell
    The current Cara Therapeutics [CARA] share price is $4.75. The Score for CARA is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.

Cara Therapeutics Stock Info

Market Cap:
21.7M
Price in USD:
4.75
Share Volume:
134.6K

Cara Therapeutics 52-Week Range

52-Week High:
13.80
52-Week Low:
2.71
Sell
27
Cara Therapeutics (CARA) is a Sell

Cara Therapeutics Share Price Forecast

Is Cara Therapeutics Stock a Buy?

  • Cara Therapeutics share price is 4.75 while CARA 8-day exponential moving average is 4.98, which is a Sell signal.
  • The stock price of CARA is 4.75 while Cara Therapeutics 20-day EMA is 4.67, which makes it a Buy.
  • Cara Therapeutics 50-day exponential moving average is 4.19 while CARA share price is 4.75, making it a Buy technically.
  • CARA stock price is 4.75 and Cara Therapeutics 200-day simple moving average is 7.22, creating a Sell signal.

Fundamental Analysis of Cara Therapeutics

Is Cara Therapeutics a good investment?

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.25 per share, and a decrease next year of $0.00 per share.

Technical Analysis of Cara Therapeutics

Should I short Cara Therapeutics stock?

* Cara Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.